Karin Hoogendoorn
Director/Miembro de la Junta en Centre For Advanced Medical Products .
Perfil
Karin Hoogendoorn is currently a Director at the Centre For Advanced Medical Products.
Previously, she worked as an Associate Director at Novartis AG and Janssen Biologics BV.
She also served as a Director at Idogen AB and an Independent Director at Elicera Therapeutics AB.
Additionally, she was the Head of Chemistry, Manufacturing & Controls at Mendus AB.
Dr. Hoogendoorn holds a graduate degree from the University of Leiden and a doctorate degree from the University of Utrecht.
Cargos activos de Karin Hoogendoorn
Empresas | Cargo | Inicio |
---|---|---|
Centre For Advanced Medical Products | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Karin Hoogendoorn.
Empresas | Cargo | Fin |
---|---|---|
IDOGEN AB (PUBL) | Director/Miembro de la Junta | 12/05/2020 |
ELICERA THERAPEUTICS AB | Director/Miembro de la Junta | - |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | - |
NOVARTIS AG | Corporate Officer/Principal | - |
MENDUS AB | Corporate Officer/Principal | - |
Formación de Karin Hoogendoorn.
University of Leiden | Graduate Degree |
University of Utrecht | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MENDUS AB | Health Technology |
IDOGEN AB (PUBL) | Health Technology |
NOVARTIS AG | Health Technology |
ELICERA THERAPEUTICS AB | Health Technology |
Empresas privadas | 2 |
---|---|
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Health Technology |
Centre For Advanced Medical Products |
- Bolsa de valores
- Insiders
- Karin Hoogendoorn